Daisy Genomics
PrivateLast Round
Seed
Dec 17, 2025
Total Funding Raised
$8M
Company Overview
Daisy Genomics operates in Healthcare & Life Sciences and is based in Albuquerque, New Mexico. Its latest recorded funding round was a Seed round in December 2025.
Daisy Genomics is a biotechnology company that develops a proprietary physics-based optical sequencing platform using nanochannels and surface-enhanced Raman spectroscopy (SERS) to detect DNA and RNA sequences for applications in precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Daisy Genomics Comparables
Compare Daisy Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quantapore, Inc. | 84% | |
| Swan Genomics | 77% | |
| Pacific Biosciences of California, Inc. | 74% |
For institutional investors. Book with your work email.
Daisy Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 17, 2025 | ||||
| Grant | Aug 31, 2022 | ||||
| Series B | Oct 18, 2021 | ||||
| Seed | Aug 16, 2017 |
For institutional investors. Book with your work email.
Daisy Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sun Mountain Capital | Series B |
| Cottonwood Technology Fund | Seed, Series B |
| Waves Capital Partners | Seed |
| Tramway Venture Partners | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2025
Monthly visitors grew 58% MoM.
- Oct 29, 2024
Monthly visitors increased 54% MoM, reaching 2,000.
For institutional investors. Book with your work email.
Daisy Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Daisy Genomics's valuation, stock price, and market status.
Is Daisy Genomics a public or private company?
Daisy Genomics is a private company.
What is the current stock price of Daisy Genomics?
Daisy Genomics is a private company, so its shares have no public market price. Caplight tracks Daisy Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Daisy Genomics worth (valuation)?
Valuation information for Daisy Genomics is not publicly available.
Can I buy Daisy Genomics stock?
Daisy Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Daisy Genomics's last funding round?
Daisy Genomics's most recent funding round was Seed on December 17, 2025.
Who are the main investors in Daisy Genomics?
Key investors in Daisy Genomics include Cottonwood Technology Fund, Tramway Venture Partners.
Will Daisy Genomics IPO soon?
No public IPO plans have been announced for Daisy Genomics.
How can I track Daisy Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Daisy Genomics's shares on secondary markets.